Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

Table 2

IK MPB64_TCN_ISH as response. 99 samples, positive : negative = 69 : 30.

Clinical endpoints	value	Values	MTBL positive	MTBL negative
Category	0.0832	Squamous cell carcinoma (SCC)	29	6
		Lung adenocarcinoma (LAC)	28	13
		Bronchioloalveolar carcinoma (BAC)	8	6
		Small cell lung carcinoma (SCLC)	4	5
Clinical stage	0.4328	I, II	27	15
		III, IV	42	15
Tumor size	0.9732	≤3 cm	28	13
		>3 cm	41	17
Lymph node metastasis	0.1409	Yes	49	16
		No	20	14
Gender	0.3929	Male	31	10
		Female	38	20
Pathology grade	0.4674	I	13	6
		II	34	11
		III	22	13
Age	0.9579		59.86 (mean), 9.53 (sd)	59.73 (mean), 10.89 (sd)